Results 101 to 110 of about 5,796 (217)

The Evolving Landscape of Respiratory Syncytial Virus (RSV) Prophylaxis in Infants. [PDF]

Cureus
Chamarthi S, Gupta S, Chamarthi VS.
europepmc   +1 more source

Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo [PDF]

, 2018
Shamir R. Jacobino, Maaike Nederend, Josephine F. Reijneveld, Daan Augustijn, J.H. Marco Jansen, Jan Meeldijk, Karli R. Reiding, Manfred Wuhrer, Frank E. J. Coenjaerts, C. Erik Hack, Louis Bont, Jeanette H.W. Leusen   +11 more
openalex   +1 more source

Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody. [PDF]

EBioMedicine
Farías MA, Andrade CA, Loaiza RA, Rodríguez-Guilarte L, Muñoz JT, Pereira-Sánchez P, Muñoz-Durango N, Pizarro-Ortega MS, Diethelm-Varela B, Pereira-Serrano A, Ramírez RA, Chávez JL, Bohmwald K, Soto JA, González PA, Bueno SM, Kalergis AM.   +16 more
europepmc   +1 more source

Palivizumab for Severe Respiratory Syncytial Virus Infection in Immunocompetent Adults: A Case Series. [PDF]

Infect Drug Resist
Zhong JY, Yeh TK, Huang HP, Ho CM, Liu PY, Fu YC.   +5 more
europepmc   +1 more source

Avaliação da susceptibilidade de mutantes de escape do vírus sincicial respiratório frente ao Palivizumab pelo método de microneutralização <i>in vitro</i>. [PDF]

, 2018
Stella Rezende Melo
openalex   +1 more source

Strengthening RSV prevention in early life through new generation strategies. [PDF]

J Pediatr (Rio J)
Mejias A, Ramilo O.
europepmc   +1 more source

An engineered palivizumab IgG2 subclass for synthetic gp130 and fas-mediated signaling [PDF]

Christoph Wittich, Julia Ettich, Marcel Hertell, Biswajit Roy, Haifeng C. Xu, Doreen M. Floß, Svenja Philipp, Jürgen Scheller   +7 more
openalex   +1 more source

Discovery and molecular mechanism of potent neutralizing antibody from humanized mice with respiratory syncytial virus. [PDF]

PLoS Pathog
Zhang Z, Feng R, Zhang L, Yang Q, Chen X, Wang X, Nie C, Peng W, Wang X, Zhu L, Guo Y, Sun Z.   +11 more
europepmc   +1 more source

Palivizumab en la prevención de infección por virus respiratorio sincicial

, 2002
José Luis Martínez M.
openalex   +1 more source

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants [PDF]

, 2017
Melissa Pavilack, Robert Clifford, Tara Gonzales, Amanda M. Kong, Sally W. Wade, Kimmie McLaurin   +5 more
openalex   +1 more source